Nimesul (Nimesulide)

Nimesulide, the active ingredient in Nimesul, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It is employed to relieve pain and reduce inflammation in adult patients with conditions such as osteoarthritis, dysmenorrhea, and fever.

GNH USA supplies Nimesul as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory‑approved batches to global healthcare providers.

Nimesulide is used to manage pain and inflammatory conditions by targeting the cyclo‑oxygenase pathway.

- Pain relief: alleviates mild to moderate acute pain. - Osteoarthritis: reduces joint pain and improves mobility. - Dysmenorrhea: eases menstrual cramps and associated discomfort. - Fever: lowers elevated body temperature in febrile states. - Inflammatory disorders: diminishes swelling in conditions such as tendonitis.

Nimesulide may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea or dyspepsia. - Headache. - Mild skin rash.

Serious or Rare Side Effects: - Hepatotoxicity (severe liver injury). - Gastrointestinal bleeding or ulcer perforation. - Severe skin reactions such as Stevens‑Johnson syndrome.

Before prescribing Nimesulide, clinicians should consider several safety measures.

- Assess liver function: obtain baseline hepatic enzymes before initiating therapy. - Avoid in known hypersensitivity: do not use if the patient has a previous NSAID allergy. - Caution with cardiovascular disease: limit use in patients with a history of heart failure or ischemic heart disease. - Contraindicated in pregnancy: avoid during the third trimester and use only if benefits outweigh risks. - Monitor renal function: adjust or discontinue if renal impairment develops. - Store at room temperature: keep in the original container, protect from moisture and light.

Nimesulide can interact with several drug classes, requiring careful assessment.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Lithium: elevated serum lithium levels.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may affect renal function. - Diuretics: potential for reduced renal clearance. - SSRIs or SNRIs: modest increase in bleeding tendency.